Infectious Disease Doctors in La Crosse, WI Accepting Medicare

8 Infectious Disease doctors found. Showing 1 - 8

Dr. Deena M Athas, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

James E Glasser, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300    Fax: 608-775-4467

Dr. Montaser Bilbisi, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

David R Mcnamara, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

Todd J Kowalski, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

Laura Felley, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

Sylvia A Moser, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

William A Agger, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

News Archive

Transcendental Meditation technique produces unique state of "restful alertness"

A new EEG study conducted on college students at American University found they could more highly activate the default mode network, a suggested natural "ground state" of the brain, during their practice of the Transcendental Meditation technique. This three-month randomized control study is published in a special issue of Cognitive Processing dedicated to the Neuroscience of Meditation and Consciousness, Volume 11, Number 1, February, 2010.

Embryos that are selected out as abnormal can undergo chromosomal modifications

Ms Tsvia Frumkin, from the Racine IVF unit, LIS Maternity Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel, will tell the conference that her team's findings meant that the results of preimplantation genetic screening (PGS) for chromosomal abnormalities were not always reliable and should be interpreted with caution.

Novel heart attack treatment results presented at premier USA cardiology forum

Regenerative medicine company Mesoblast Limited (ASX:MSB; USADR:MBLTY) has announced that positive preclinical trial results were presented at the American Heart Association's annual conference in Chicago showing that the company's proprietary "off-the-shelf" stem cells can be injected simply, safely, and effectively into the coronary arteries after a heart attack to prevent heart failure.

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.

Read more Medical News

› Verified 3 days ago